Connect Biopharma Limite...

NASDAQ: CNTB · Real-Time Price · USD
2.03
-0.12 (-5.58%)
At close: Aug 15, 2025, 1:08 PM

Connect Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
26.03M n/a n/a n/a
Cost of Revenue
n/a 988K 1.03M n/a
Gross Profit
26.03M -988K -1.03M n/a
Operating Income
-22.45M -62.07M -117.66M -99.15M
Interest Income
4.45M 5.2K 1.56M 97.67K
Pretax Income
-15.4M -59.38M -116.12M -204.94M
Net Income
-15.63M -59.5M -116.42M -205.21M
Selling & General & Admin
19.23M 13.53M 20.37M 19.23M
Research & Development
29.26M 51.91M 95.26M 81.34M
Other Expenses
n/a -4.35M -940.31K -2.98M
Operating Expenses
48.48M 62.07M 114.69M 97.59M
Interest Expense
n/a n/a 21.03K 6.91K
Selling & Marketing Expenses
n/a 13.51M n/a n/a
Cost & Expenses
48.48M 62.07M 114.69M 97.59M
Income Tax Expense
223K 120K 297.52K 266.47K
Shares Outstanding (Basic)
55.21M 55.07M 55.04M 52.27M
Shares Outstanding (Diluted)
55.21M 55.07M 55.04M 52.27M
EPS (Basic)
-0.28 -1.08 -14.5 -25
EPS (Diluted)
-0.28 -1.08 -14.5 -25
EBITDA
-22.45M -58.37M -111.31M -204.93M
EBIT
-22.45M -59.36M -118.04M -202.36M
Depreciation & Amortization
660K 988K 1.01M 640.98K